Mini-Dose Pump-Prime Aprotinin Inhibited Enhanced Fibrinolytic Activity and Reduced Blood Loss and Transfusion Requirements After Coronary Artery Bypass Surgery
This investigation was undertaken to evaluate the effects of mini-dose pump prime only aprotinin (70 mg) on the hemostatic parameters and blood transfusion requirements in patients undergoing on-pump coronary artery bypass surgery (CABG).